Dela Cerna, Dionesio C.

HRN: 25-30-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/18/2024
06/25/2024
IV
2.25g
Q6H
Sepsis Sec To DM Foot, Right
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bone & JointSkin & Soft TissueDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: